Literature DB >> 11309211

Management of opioid-induced constipation.

D M Thorpe1.   

Abstract

Constipation is an expected side effect of opioid use and as such should be treated prophylactically. However, because it is often overlooked and under-appreciated it is one of the most common reasons patients avoid or abandon opioid use and, as a result, suffer pain needlessly. Thorough assessment, ongoing evaluation, and patient teaching are key factors in establishing an effective bowel regimen. A bowel clean-out is indicated for patients who have not had a bowel movement in more than 5 days. Once any impactions have been eliminated, a regular regimen of senna and docusate is recommended. Dietary modifications, fluids, and exercise are important but usually not sufficient to overcome opioid-induced constipation. Although many of the medicines that are used to treat pain and related symptoms come with a significant potential for distressing side effects, it is important to understand that most side effects, especially constipation, can be managed and quality of life can be preserved without sacrificing needed analgesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309211     DOI: 10.1007/s11916-001-0037-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  5 in total

Review 1.  Multidisciplinary care of the terminally ill patient.

Authors:  S O'Mahony; N Coyle; R Payne
Journal:  Surg Clin North Am       Date:  2000-04       Impact factor: 2.741

Review 2.  ABC of palliative care. Constipation and diarrhoea.

Authors:  M Fallon; B O'Neill
Journal:  BMJ       Date:  1997-11-15

Review 3.  Managing bowel elimination problems in patients with cancer.

Authors:  A Bisanz
Journal:  Oncol Nurs Forum       Date:  1997-05       Impact factor: 2.172

4.  Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.

Authors:  D B Murphy; J A Sutton; L F Prescott; M B Murphy
Journal:  Anesthesiology       Date:  1997-10       Impact factor: 7.892

5.  An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.

Authors:  N P Sykes
Journal:  Palliat Med       Date:  1996-04       Impact factor: 4.762

  5 in total
  20 in total

1.  More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer.

Authors:  Eric J Roeland; Christopher J Sera; Joseph D Ma
Journal:  Support Care Cancer       Date:  2019-07-22       Impact factor: 3.603

2.  Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec.

Authors:  R E Williams; N Bosnic; C T Sweeney; A W Duncan; K B Levine; M Brogan; S F Cook
Journal:  Pain Res Manag       Date:  2008 Sep-Oct       Impact factor: 3.037

Review 3.  [Opioid-induced bowel dysfunction: a literature analysis on pathophysiology and treatment].

Authors:  Jürgen Osterbrink; Ute Haas
Journal:  Wien Med Wochenschr       Date:  2008

4.  Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; David L Stevens; Essie Komla; Dana E Selley; William L Dewey; Hamid I Akbarali; Yan Zhang
Journal:  ACS Chem Neurosci       Date:  2018-07-23       Impact factor: 4.418

5.  Effects of methylnaltrexone on guinea pig gastrointestinal motility.

Authors:  Laura Anselmi; Jennifer Huynh; Gaia Vegezzi; Catia Sternini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-30       Impact factor: 3.000

Review 6.  Opioid-induced bowel dysfunction: pathophysiology and management.

Authors:  Christina Brock; Søren Schou Olesen; Anne Estrup Olesen; Jens Brøndum Frøkjaer; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

7.  In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.

Authors:  A Kuo; B D Wyse; W Meutermans; M T Smith
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 8.  Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction.

Authors:  Jakob Lykke Poulsen; Christina Brock; Anne Estrup Olesen; Matias Nilsson; Asbjørn Mohr Drewes
Journal:  Clin Exp Gastroenterol       Date:  2014-09-19

Review 9.  Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.

Authors:  S J Panchal; P Müller-Schwefe; J I Wurzelmann
Journal:  Int J Clin Pract       Date:  2007-05-04       Impact factor: 2.503

Review 10.  Opioid-induced constipation: pathophysiology, clinical consequences, and management.

Authors:  Lalit Kumar; Chris Barker; Anton Emmanuel
Journal:  Gastroenterol Res Pract       Date:  2014-05-05       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.